Jesse Selnick - Jul 14, 2021 Form 3 Insider Report for Sight Sciences, Inc. (SGHT)

Role
Chief Financial Officer
Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Jesse Selnick
Stock symbol
SGHT
Transactions as of
Jul 14, 2021
Transactions value $
$0
Form type
3
Date filed
7/14/2021, 08:54 PM
Next filing
Jul 19, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SGHT Stock Option (Right to Buy) Jul 14, 2021 Common Stock 120K $0.35 Direct F1
holding SGHT Stock Option (Right to Buy) Jul 14, 2021 Common Stock 40K $0.62 Direct F2
holding SGHT Stock Option (Right to Buy) Jul 14, 2021 Common Stock 300K $10.96 Direct F3
holding SGHT Series A Redeemable Convertible Preferred Stock Jul 14, 2021 Common Stock 1.74M See Footnote F4, F5
holding SGHT Series B Redeemable Convertible Preferred Stock Jul 14, 2021 Common Stock 237K See Footnote F4, F5
holding SGHT Series C Redeemable Convertible Preferred Stock Jul 14, 2021 Common Stock 243K See Footnote F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying securities on January 23, 2019 and in 36 equal monthly installments thereafter.
F2 The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on April 18, 2019.
F3 The option vests and becomes exercisable in 48 substantially equal monthly installments commencing on June 24, 2021.
F4 The preferred stock is convertible into common stock on a 2 for 1 basis and will automatically convert upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F5 These shares are held of record by Sight Sciences Angels, LP ("Sight Sciences Angels"). The reporting person is a Managing Member of the General Partner of Sight Sciences Angels and may be deemed to beneficially own the shares of common stock held by Sight Sciences Angels.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney